Shareholders' equity · 2011–2025
Niagen Bioscience shareholders' equity
$76.5M+66.0% · FY2025
Niagen Bioscience (NAGE) reported $76.5M in shareholders' equity for fiscal 2025, +66.0% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $76.5M | +66.0% | Open → |
| FY20242024-12-31 | $46.1M | +62.0% | Open → |
| FY20232023-12-31 | $28.5M | −0.8% | Open → |
| FY20222022-12-31 | $28.7M | −9.6% | Open → |
| FY20212021-12-31 | $31.7M | +93.2% | Open → |
| FY20202020-12-31 | $16.4M | −19.7% | Open → |
| FY20192019-12-31 | $20.4M | −24.8% | Open → |
| FY20182018-12-31 | $27.2M | −49.5% | Open → |
| FY20172017-12-30 | $53.8M | +439.7% | Open → |
| FY20162016-12-31 | $10.0M | +89.1% | Open → |
| FY20152016-01-02 | $5.3M | +31.9% | Open → |
| FY20142015-01-03 | $4.0M | −29.4% | Open → |
| FY20132013-12-28 | $5.7M | +41.9% | Open → |
| FY20122012-12-29 | $4.0M | +55.9% | Open → |
| FY20112011-12-31 | $2.6M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +27.5%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience shareholders' equity |url=https://companiesranked.com/en/company/niagen-bioscience/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/shareholders-equityBibTeX
@misc{companiesranked-en-company-niagen-bioscience-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001386570-26-000043 · August 4, 2026
{{cite web |title=Niagen Bioscience shareholders' equity — 10-Q (0001386570-26-000043) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000043/cdcx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.